An Insight into Red Cell Distribution Width Fluctuations and Pregnancy Outcomes in HIV-Affected Women

Red Cell Distribution Width (RDW), a measure of the variability in red blood cell size, has gained attention as a potential biomarker for assessing pregnancy outcomes, particularly in women living with HIV. This review explores the relationship between RDW fluctuations and maternal and fetal health during pregnancy in HIV-affected women. Elevated RDW levels have been associated with various adverse outcomes, including preeclampsia, preterm birth, and low birth weight, which are of significant concern in this population. HIV infection introduces additional complexity to pregnancy, increasing the risk of complications for both mother and infant. The interaction between HIV, antiretroviral therapy, and RDW levels can influence maternal hematological health, potentially affecting pregnancy outcomes. This review examines current literature to understand how RDW variations correlate with these complications and the implications for maternal and fetal well-being.